Clinical Trials for Heart Diseases

Currently registered clinical trials for Heart Diseases from ClinicalTrials.gov. 22 recruiting, 50 total studies.

This content is for informational purposes only. Always consult a healthcare professional.

Source: ClinicalTrials.gov — U.S. National Library of Medicine — A database of privately and publicly funded clinical studies conducted around the world (U.S. National Library of Medicine, public domain).

This page lists clinical trials related to Heart Diseases from the ClinicalTrials.gov database.

Trial Summary

  • Total studies: 50
  • Recruiting: 22
  • Active, not recruiting: 6
  • Completed: 8
  • Other: 14

Results are refreshed periodically and may not reflect the most current information available from ClinicalTrials.gov.

Recruiting Trials

NCT00341237 — Personalized Environment and Genes Study

StatusRecruiting
PhaseN/A
SponsorNational Institute of Environmental Health Sciences (NIEHS)
Enrollment25000
Study TypeOBSERVATIONAL
ConditionsDiabetes; Heart Disease; Asthma

Despite the overwhelming focus on genetic and genomic causes of human disease over the past two decades, it has been estimated that genetics is currently known to explain only 20% and 40% of the etiology of common disease. Thus, it is becoming increasingly apparent that human disease is a consequence of both genetic susceptibility and environmental exposures. Importantly, while individuals cann…

NCT01143454 — Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

StatusRecruiting
PhaseN/A
SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Enrollment5000
Study TypeOBSERVATIONAL
ConditionsMetabolic Disease; Obesity; Li-Fraumeni Syndrome; Cardiomyopathy; Atherosclerosis
Interventions

Background:

- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at a high risk for heart diseases or diseases of their blood vessels. Depending on the condition being studied, both affected and nonaffected individuals may be asked to provide blood and other samples and may undergo tests to evaluate the …

NCT01621594 — Evaluating New Radiation Techniques for Cardiovascular Imaging

StatusRecruiting
PhaseN/A
SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Enrollment5000
Study TypeINTERVENTIONAL
ConditionsCoronary Disease
Interventions

Title: Evaluating New Radiation Techniques for Cardiovascular Imaging

Background:

Cardiac CT angiography is associated with radiation exposure. Different methods of creating CT pictures have been developed to reduce the radiation dose to the subject. The purpose of this research study is to learn whether these low dose research imagings are accurate or predict subject outcomes.

Cardiac CT is…

NCT04968808 — Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)

StatusRecruiting
PhaseN/A
SponsorChonnam National University Hospital
Enrollment1014
Study TypeINTERVENTIONAL
ConditionsMyocardial Infarction, Acute; Multi-Vessel Coronary Artery Stenosis; Multi Vessel Coronary Artery Disease
Interventions;

Many patients with non-ST-segment elevation myocardial infarction (NSTEMI) have multivessel coronary artery disease (MVD), which is associated with poor clinical outcomes. However, there have been few studies regarding revascularization strategy in patients with NSTEMI and MVD. Therefore, we planned to perform prospective, open-label, randomized trial to evaluate the efficacy and safety of imme…

NCT05061004 — Cephea Early Feasibility Study

StatusRecruiting
PhaseN/A
SponsorAbbott Medical Devices
Enrollment50
Study TypeINTERVENTIONAL
ConditionsMitral Regurgitation
Interventions

The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.

NCT05519046 — Cardiac Contractility Modulation in Chagas Heart Disease

StatusRecruiting
PhaseN/A
SponsorInCor Heart Institute
Enrollment60
Study TypeINTERVENTIONAL
ConditionsChagas Cardiomyopathy; Heart Failure; Systolic Dysfunction; Right Bundle Branch Block and Left Anterior Fascicular Block; Right Bundle Branch Block and Left Posterior Fascicular Block
Interventions;

Chagas disease is an endemic problem in Latin America, where millions of people are chronically infected with T. cruzi. Recently, it was assumed to have clinical and epidemiological relevance in several other countries due to migratory and globalizing social factors. CCC occurs in 30-50% of infected individuals, causing considerable morbidity/mortality rates. Heart failure is the most prevalent…

NCT05172960 — ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

StatusRecruiting
PhaseN/A
SponsorEdwards Lifesciences
Enrollment1234
Study TypeINTERVENTIONAL
ConditionsAortic Stenosis, Severe
Interventions;

The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects with symptomatic, severe, calcific aortic stenosis (AS).

StatusRecruiting
PhasePhase 1 / Phase 2
SponsorVirginia Commonwealth University
Enrollment70
Study TypeINTERVENTIONAL
ConditionsHeart Failure; Heart Dysfunction
Interventions; ;

To determine feasibility of recruitment and tolerability of treatment with sacubitril-valsartan among adult age survivors of cancer diagnosed at or before age 39 who have stage B heart failure.

NCT06279793 — Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

StatusRecruiting
PhasePhase 2
SponsorGCP-Service International West GmbH
Enrollment550
Study TypeINTERVENTIONAL
ConditionsIntensive Care Unit; Coronary Artery Bypass Grafting (CABG); High Risk Patients; Cardiopulmonary Bypass; Elective Cardiac Surgery
Interventions;

The MODIFY CSX study is a prospective, randomized, placebo-controlled trial conducted in heart centers in Germany and Italy.

A total of 550 high-risk cardiac surgery patients will receive either 0.20 g fish oil/kg body weight (BW) + standard of care versus same volume of placebo (NaCl) + standard of care.

NCT05670132 — Neuro-cardiac Rehabilitation in Youth With Congenital Heart Disease (QUALINEUROREHAB)

StatusRecruiting
PhaseN/A
SponsorUniversity Hospital, Bordeaux
Enrollment192
Study TypeINTERVENTIONAL
ConditionsCongenital Heart Disease
Interventions;

Remarkable progress in paediatric cardiology and surgery have led to the substantial increase of congenital heart disease (CHD) survivors. Long-term outcomes in rare and complex CHD have become a critical priority as three major sources of morbidity have been identified in this population: neurodevelopmental sequelae, mental health issues and reduced exercise capacity. These challenges adversel…

NCT07091682 — Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

StatusRecruiting
PhaseN/A
SponsorBiotronik AG
Enrollment100
Study TypeINTERVENTIONAL
ConditionsCoronary Artery Disease; Atherosclerosis of Coronary Artery; Myocardial Ischemia; Ischemic Heart Disease; Acute Coronary Syndromes
Interventions

The study objective is the assessment of safety and clinical performance of Freesolve 35- and 40-mm in de novo coronary artery lesions up to 38 mm length.

NCT06909565 — Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

StatusRecruiting
PhasePhase 4
SponsorDuke University
Enrollment6000
Study TypeINTERVENTIONAL
ConditionsPercutaneous Coronary Intervention; Peripheral Endovascular Intervention
Interventions;

V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial revascularization. Inclisiran is a subcutaneous, twice-yearly injection that is FDA-approved as an adjunct with statin therapy and on the market to lower LDL-C in high-risk populations.

NCT01311323 — Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease

StatusRecruiting
PhaseN/A
SponsorAmerican Heart of Poland
Enrollment1000
Study TypeINTERVENTIONAL
ConditionsMultivessel Coronary Artery Disease; Acute Coronary Syndrome
Interventions;

MILESTONE STUDY is dedicated to problems connected with patients with multivessel coronary artery disease and/or with left main narrowing who present symptoms of acute ischemia. For such kind of patients according to current ACC/AHA guidelines CABG (surgical revascularization) is recommended as a treatment method. In comparison with CABG, recent studies have shown that PCI (percutaneous coronar…

NCT07175428 — Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

StatusRecruiting
PhasePhase 2
SponsorRegeneron Pharmaceuticals
Enrollment1200
Study TypeINTERVENTIONAL
ConditionsAtrial Fibrillation (AF)
Interventions; ;

This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too fast and unevenly. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillation.

The aim of the study is to see how well REGN7508 and REGN9933 work in patients that get medi…

NCT07194265 — A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System

StatusRecruiting
PhaseN/A
SponsorAnteris Technologies Ltd.
Enrollment1650
Study TypeINTERVENTIONAL
ConditionsSevere Aortic Stenosis; Valve-in-valve Procedures
Interventions;

Prospective, randomized, controlled, multicenter, international study.

Up to 1054 subjects with a severe native calcific aortic stenosis who are determined by the local Heart Team to have an indication for Transcatheter Aortic Valve Replacement (TAVR), will be enrolled in the ‘All Comers Randomized Cohort’. Subjects will be randomized 1:1 to receive either the DurAVR® THV System or any commerc…

NCT06736899 — Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions

StatusRecruiting
PhaseN/A
SponsorFundación EPIC
Enrollment200
Study TypeINTERVENTIONAL
ConditionsCoronary Artery Disease; Coronary Disease
Interventions;

Clinical research with medical devices indicated in accordance with the CE marking, led by researchers, multicenter, open, prospective, randomized and controlled. Patients are randomized to treatment with a conventional balloon and then a coronary stent or to initial plaque modification with Orbital Atherectomy (OA) and then a coronary stent. To evaluate the efficacy and safety of OA in the ade…

NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

StatusRecruiting
PhaseN/A
SponsorFundación EPIC
Enrollment700
Study TypeINTERVENTIONAL
ConditionsCardiovascular Diseases; Myocardial Ischemia; Heart Diseases; Arteriosclerosis; Arterial Occlusive Diseases
Interventions;

The OPTIMAL randomized clinical trial has been designed to compare two imaging strategies and to test the hypothesis that a calcium modification strategy informed by coronary CT angiography (CCTA) will improve procedural efficiency and effectiveness compared with the current standard of care (IVUS-guided PCI) while achieving similar clinical outcomes in patients with hemodynamically significant…

NCT07358611 — Non-invasive Mapping-Guided Atrial Fibrillation Ablation

StatusRecruiting
PhaseN/A
SponsorHospital Clinic of Barcelona
Enrollment30
Study TypeINTERVENTIONAL
ConditionsAtrial Fibrillation (AF)
Interventions

The goal of this pilot study is to test if noninvasive global mapping can guide catheter ablation defining personalized targets and improve the therapy of atrial fibrillation. It will also test the safety of such an approach. The main questions it aims to answer are:

  • Does ablation of targets defined by noninvasive global mapping improve rates of acute atrial fibrillation termination?
  • Does …

NCT07691307 — A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement

StatusRecruiting
PhaseN/A
SponsorJiangsu Trulive Medical Co., Ltd
Enrollment180
Study TypeINTERVENTIONAL
ConditionsTricuspid Valve Regurgitation; Tricuspid Valve Insufficiency; Tricuspid Valve Disease
Interventions;

Pivotal trial to evaluate the safety and effectiveness of the TruGamma tricuspid valve replacement system

NCT07465653 — A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

StatusRecruiting
PhasePhase 1
SponsorNovartis Pharmaceuticals
Enrollment12
Study TypeINTERVENTIONAL
ConditionsHeart Failure With Reduced Ejection Fraction
Interventions; ;

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at two different doses in participants with chronic stable heart failure with reduced or mildly reduced ejection fraction (HFrEF/HFmrEF).

NCT07517263 — An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

StatusRecruiting
PhasePhase 3
SponsorNovartis Pharmaceuticals
Enrollment5700
Study TypeINTERVENTIONAL
ConditionsCardiovascular Disease and Lipoprotein(a)
Interventions

This open-label extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed the double-blind parent study (CTQJ230A12301).

NCT07296744 — Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

StatusRecruiting
PhaseN/A
SponsorSupira Medical
Enrollment358
Study TypeINTERVENTIONAL
ConditionsCoronary Artery Disease; High Risk Percutaneous Coronary Intervention; Interventional Cardiology; Mechanical Circulatory Support
Interventions;

The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercially available Impella systems (comparator device).

Active, Not Recruiting

NCT00005398 — University of North Carolina Alumni Heart Study

StatusActive, not recruiting
PhaseN/A
SponsorDuke University
Enrollment6340
Study TypeOBSERVATIONAL
ConditionsCardiovascular Diseases; Heart Diseases; Coronary Disease; Depression
Interventions

To continue surveillance of the participants in the University of North Carolina Alumni Heart Study, which tests the hypothesis that hostility and related psychosocial factors are involved in the pathogenesis of coronary heart disease.

NCT03706833 — Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

StatusActive, not recruiting
PhaseN/A
SponsorEdwards Lifesciences
Enrollment1247
Study TypeINTERVENTIONAL
ConditionsDegenerative Mitral Valve Disease; Mitral Regurgitation; Mitral Insufficiency; Functional Mitral Regurgitation
Interventions;

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)

NCT04212962 — Transitional Care Model Evaluation 2020

StatusActive, not recruiting
PhaseN/A
SponsorMathematica Policy Research, Inc.
Enrollment962
Study TypeINTERVENTIONAL
ConditionsCHF - Congestive Heart Failure; COPD; Pneumonia
Interventions;

The study is a randomized controlled trial to estimate the effects of the transitional care model (TCM) on hospital admissions and patients’ experience during the year following the patient’s qualifying discharge. The University of Pennsylvania, where TCM was developed, will be the coordinating center for the implementation. The study will be conducted in three large health systems spread throu…

NCT06304233 — The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease

StatusActive, not recruiting
PhaseN/A
SponsorNorwegian University of Science and Technology
Enrollment120
Study TypeOBSERVATIONAL
ConditionsHeart Diseases; Heart; Functional Disturbance; Schizophrenia
Interventions; ;

To study the association between DISC1 RNA expression levels and cardiac function in patients with schizophrenia.

NCT06094491 — Virtual Diabetes Group Visits Across Health Systems

StatusActive, not recruiting
PhaseN/A
SponsorUniversity of Chicago
Enrollment720
Study TypeINTERVENTIONAL
ConditionsT2DM (Type 2 Diabetes Mellitus); Hypertension; Heart Disease Chronic; Stroke; Hyperlipidemias
Interventions

The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).

NCT06853626 — One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care

StatusActive, not recruiting
PhaseN/A
SponsorUniversity of Oslo
Enrollment2500
Study TypeINTERVENTIONAL
ConditionsAcute Myocardial Infarction (AMI); Chest Pain; Acute Coronary Syndromes (ACS); Non-cardiac Chest Pain; Troponin
Interventions

Acute chest pain is a prevalent medical emergency in primary emergency care settings. Triage of chest pain prior to hospital admission presents significant challenges due to the absence of sufficiently sensitive diagnostic tools. Clinical signs, symptoms, risk assessment scores, or a normal electrocardiogram (ECG) can reliably exclude acute myocardial infarction (MI). This diagnostic uncertaint…

Not Yet Recruiting

NCT07689760 — Explainable AI for Predicting Hospital Admissions in Heart Failure: ExplAIn-HF

StatusNot yet recruiting
PhaseN/A
SponsorMedisch Spectrum Twente
Enrollment95
Study TypeOBSERVATIONAL
ConditionsHeart Failure

The goal of this observational study is to develop and validate an XAI based model that predicts HF events and identifies modifiable con-tributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care in patients with heart failure. The main objectives of the study are:

  1. To develop and validate an XAI based model that predicts HF events…

NCT07689981 — The Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals With Tiletamine Use Disorder

StatusNot yet recruiting
PhaseN/A
SponsorShanghai Mental Health Center
Enrollment30
Study TypeINTERVENTIONAL
ConditionsTiletamine Use Disorder; Substance Use Disorder (SUD); Drug Craving
Interventions;

Participants diagnosed with tiletamine use disorder will be assigned to active or sham taVNS for 5 days. Clinical outcomes ( e.g., behavioral paradigms measures and clinical scales ) and physiological markers (e.g., EEG and ECG) will be evaluated at baseline, post-treatment, and 3-month follow-ups to determine therapeutic efficacy and mechanisms of action.

NCT07689591 — Noninvasive Artificial Venous Stasis for Reperfusion in STEMI

StatusNot yet recruiting
PhaseN/A
SponsorFirat University
Enrollment500
Study TypeOBSERVATIONAL
ConditionsSTEMI - ST Elevation Myocardial Infarction

This prospective, randomized study was designed to evaluate whether the noninvasive artificial venous stasis / RE-START procedure, administered prior to primary percutaneous coronary intervention, increases the frequency of spontaneous coronary reperfusion in the infarct-related artery.

NCT07690436 — Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM

StatusNot yet recruiting
PhaseN/A
SponsorAstraZeneca
Enrollment500
Study TypeOBSERVATIONAL
ConditionsTransthyretin Amyloid Cardiomyopathy

This multicenter pilot study will enroll adult participants with a confirmed clinical diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) and heart failure (HF) controls with documentation within the past 2 years that either excludes ATTR-CM or indicates a low probability of ATTR-CM. Ocular imaging and other study data will be collected to assess the feasibility of developing and prelim…

NCT07686900 — Dynamic Multimodal Delirium Warning After Cardiac Surgery

StatusNot yet recruiting
PhaseN/A
SponsorSoutheast University, China
Enrollment200
Study TypeOBSERVATIONAL
ConditionsPostoperative Delirium; Cardiac Surgical Procedures

After heart surgery, up to half of all patients may develop a state of sudden confusion called postoperative delirium. This condition can lead to longer time on a breathing machine, extended stays in the intensive care unit (ICU), and a slower overall recovery. Currently, doctors have no reliable way to predict delirium early enough to take preventive action. This study aims to build a computer…

NCT05372627 — NHLBI-Emory Advanced Cardiac CT Reconstruction

StatusNot yet recruiting
PhaseN/A
SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Enrollment1000
Study TypeOBSERVATIONAL
ConditionsStructural Heart Disease

Background:

Doctors use computed tomography (CT) to get detailed pictures of the heart. CT uses x-rays to gather raw data. Computers assemble this data to make the images doctors look at. A new computer technique can make higher resolution images from the same CT scans. In this natural history study, researchers will take normal CT images of the heart. They will compare those images to super h…

NCT07549490 — Human Experimental Models of Pain (HEMP)

StatusNot yet recruiting
PhaseN/A
SponsorNational Center for Complementary and Integrative Health (NCCIH)
Enrollment25
Study TypeINTERVENTIONAL
ConditionsAcute Pain
Interventions; ;

This pilot study will test an innovative way to establish how pain medicines provide analgesia in healthy adults. The study uses a group of short, controlled pain tests to look at different types of pain responses in the body. The main goal is to find out if this testing approach can show the pain-relieving effects of 2 medicines, pregabalin and naproxen versus placebo, and show how they provid…

NCT07689279 — Selection of Transcatheter Heart vaLve With Intermediate Sizing in Patients With Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement

StatusNot yet recruiting
PhasePhase 4
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Enrollment604
Study TypeINTERVENTIONAL
ConditionsAortic Stenosis, Severe
Interventions

Transcatheter aortic valve implantation (TAVI) has evolved into a standard therapy for severe aortic stenosis across all surgical risk profiles, supported by pivotal trials in high- and low-risk populations. Two types of transcatheter heart valves, balloon-expandable and self-expanding, exhibit distinct hemodynamic and structural characteristics that influence procedural strategy and long-term …

NCT07571447 — Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation

StatusNot yet recruiting
PhasePhase 4
SponsorGødstrup Hospital
Enrollment220
Study TypeINTERVENTIONAL
ConditionsAtrial Fibrillation (AF); Atrial Flutter
Interventions;

Irregular heart rhythms, known as atrial fibrillation or atrial flutter, are common conditions that can increase the risk of stroke and heart failure. A standard treatment to restore a normal rhythm is a controlled electric shock, known as cardioversion. However, if the irregular rhythm has lasted more than 24 hours, if the duration is uncertain, and if the patient has not been on blood-thinnin…

NCT07690748 — Remote Monitoring for Patients With Aortic Stenosis

StatusNot yet recruiting
PhaseN/A
SponsorBaker Heart and Diabetes Institute
Enrollment160
Study TypeOBSERVATIONAL
ConditionsAortic Stenosis

Remote-AS aims to develop a remote digital monitoring cohort of people with AS and use these data to establish a digital twin intervention to personalise risks and benefits, and optimise the time of surgical or transcatheter aortic valve replacement (AVR) referral. Our digital solution will also seek modelling for optimal care for patients to whom AVR is indicated who choose not to undergo the …

NCT07634419 — Self-directed Mobile Mindfulness to Address ICU Survivors’ Psychological Distress

StatusNot yet recruiting
PhaseN/A
SponsorDuke University
Enrollment450
Study TypeINTERVENTIONAL
ConditionsCritical Illness; Heart Failure; Sepsis; Ards; Pneumonia
Interventions;

Serious acute heart and lung illnesses like heart failure, severe COVID, and sepsis often leave survivors struggling not only physically, but also with lasting depression, anxiety, and stress. These problems that are hard to treat because access to mental health care is often limited. To help address this, the researchers created Lift, a fully automated mindfulness program designed with patient…

Enrolling by Invitation

NCT00001620 — Screening for Hematology Branch Protocols

StatusEnrolling by invitation
PhaseN/A
SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Enrollment10000
Study TypeOBSERVATIONAL
ConditionsHematologic Disease and Disorders; Donors; Healthy Volunteer

This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies.

After subjects complete the screening process, they will be offered the opportunity to participate in an active research study, or if no appropriate studies are available information and recommendations will be provided for other treatment options….

NCT06280820 — Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)

StatusEnrolling by invitation
PhaseN/A
SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Enrollment2000
Study TypeOBSERVATIONAL
ConditionsHeart Failure

Background:

More than 6.5 million people in the United States live with heart failure (HF), and more than a million new cases are diagnosed each year. Treatments have improved in recent years, but researchers want to understand more about how HF develops. To do this, they need to compare blood and other samples from many people with HF.

Objective:

To collect blood and other samples from peop…

Completed Trials

NCT01918215 — Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.

StatusCompleted
PhaseN/A
SponsorFlinders University
Enrollment453
Study TypeINTERVENTIONAL
ConditionsHeart Failure; Left Ventricular Systolic Dysfunction
Interventions;

Contemporary heart failure (HF) guidelines recommend insertion of a primary prevention implantable defibrillator (ICD) in patients with left ventricular ejection fraction less than 35% (LVEF < 35%) on maximally tolerated medical therapy. Nevertheless, there are a substantial number of HF patients who have LVEF>35% and hence do not qualify for ICD, who succumb to sudden cardiac death (SCD). At…

NCT05183178 — Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome

StatusCompleted
PhasePhase 4
SponsorVastra Gotaland Region
Enrollment17095
Study TypeINTERVENTIONAL
ConditionsAcute Coronary Syndrome
Interventions;

This study proposes to conduct the switch from ticagrelor to prasugrel in an organized stepwise manner, to allow for the evaluation of the relative efficacy of prasugrel versus ticagrelor using a stepped-wedge cluster randomized trial design.

NCT05164718 — The Norwegian Exercise in Atrial Fibrillation Trial

StatusCompleted
PhaseN/A
SponsorNorwegian University of Science and Technology
Enrollment300
Study TypeINTERVENTIONAL
ConditionsAtrial Fibrillation
Interventions;

Atrial fibrillation (AF) patients suffer a high symptom burden and reduced quality of life (QoL), high hospitalization rates and few effective treatment options. They have a high burden of cardiovascular risk factors and events. Lifestyle changes and exercise is a cornerstone of management in most chronic cardiac conditions and holds promise in AF, but the evidence is sparse and specific guidel…

NCT04577859 — Esophageal Protection Study: A Multicenter Study

StatusCompleted
PhaseN/A
SponsorAdvanced Cooling Therapy LLC, d/b/a Attune Medical
Enrollment152
Study TypeINTERVENTIONAL
ConditionsAF - Atrial Fibrillation; Complication; Atrio-Esophageal Fistula
Interventions;

Atrial fibrillation (AF) is a common debilitating heart rhythm condition that can cause heart failure and negatively impact a patient’s outlook in terms of symptoms and disability. It is an irregular fast heart rhythm disorder coming from the top chamber of the heart (left atrium). Catheter ablation treatment has been shown to be effective in controlling or eliminating AF and its associated sym…

NCT07689422 — The Effect of Web-Based Gamification Applications on Nursing Students’ Learning Regarding Cardiopulmonary Resuscitation

StatusCompleted
PhaseN/A
SponsorKaradeniz Technical University
Enrollment86
Study TypeINTERVENTIONAL
ConditionsCardiovascular Diseases; Cardiopulmonary Arrest; Web-based Gamification
Interventions

In this study, the aim was to determine students’ level of knowledge regarding cardiopulmonary resuscitation by using web-based gamification applications in nursing education, and additionally, to evaluate the secondary effects on knowledge retention and skill levels.

  1. The cardiopulmonary resuscitation training delivered through web-based gamification applications has no effect on students’ …

NCT07680192 — Educational Intervention for Patients Undergoing Cardiac Surgery

StatusCompleted
PhaseN/A
SponsorAnna Farrús Torrella
Enrollment261
Study TypeINTERVENTIONAL
ConditionsCardiovascular Surgery; Anxiety; Patient Education
Interventions

Cardiovascular surgery is associated with high levels of anxiety, uncertainty, and postoperative complications. Educational interventions led by nurses may improve patients’ psychological adaptation, self-care abilities, and recovery outcomes.

This randomized controlled trial aims to evaluate the effectiveness of a nurse-led educational program designed to prepare and support patients undergoi…

NCT06074887 — The Effect of Model-based Cardiac Rehabilitation on Self-care, Quality of Life, and Self-efficacy in Patients With Heart Failure

StatusCompleted
PhaseN/A
SponsorCukurova University
Enrollment63
Study TypeINTERVENTIONAL
ConditionsHeart Failure
Interventions

The main reason why heart failure (HF) is an important public health problem is that the incidence of HF is increasing and mortality rates remain unchanged despite the decline in the incidence of coronary artery disease. The ageing population and improved medical care services are the main factors supporting this increase. In the guidelines, education and rehabilitation are recommended for symp…

NCT07689500 — Effect of a Cooling Helmet on Postoperative Cognitive Dysfunction in Adults Undergoing Open-Heart Surgery

StatusCompleted
PhaseN/A
SponsorIndonesia University
Enrollment153
Study TypeINTERVENTIONAL
ConditionsPostoperative Cognitive Complications; Open Heart Surgery
Interventions;

Postoperative cognitive dysfunction, or POCD, is a decline in thinking, memory, attention, or executive function that may occur after surgery and anesthesia. Patients undergoing open heart surgery with cardiopulmonary bypass may have a higher risk of POCD because of changes in blood flow, inflammation, microemboli, and changes in brain oxygen supply during surgery.

Cooling the head during open…

Other (Terminated)

NCT01025947 — “Cryptogenic Stroke and Atrial Fibrillation Detection Through Implantable Loop Recorder (ILR)”

StatusTerminated
PhaseN/A
SponsorUniversity of Valencia
Enrollment100
Study TypeOBSERVATIONAL
ConditionsAtrial Fibrillation; Stroke

STUDY TYPE:

Prospective, national , multicenter, and observational study.

OBJECTIVE:

To assess the incidence of AF in patients with cryptogenic stroke who have implanted an AF detection device during a period of 2 years.

DEVICE:

Reveal XT 9529 (SQDM)

SAMPLE SIZE AND STUDY DURATION:

100 patients enrolled which will be followed during a period of 2 years.